49 results on '"Porter, John B."'
Search Results
2. Decrement in Cellular Iron and Reactive Oxygen Species, and Improvement of Insulin Secretion in a Pancreatic Cell Line Using Green Tea Extract
3. Limitations of serum ferritin to predict liver iron concentration responses to deferasirox therapy in patients with transfusion‐dependent thalassaemia
4. One‐year results from a prospective randomized trial comparing phlebotomy with deferasirox for the treatment of iron overload in pediatric patients with thalassemia major following curative stem cell transplantation
5. Iron overload across the spectrum of non‐transfusion‐dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions
6. Guidelines on red cell transfusion in sickle cell disease Part II: indications for transfusion
7. Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects
8. Utility of labile plasma iron and transferrin saturation in addition to serum ferritin as iron overload markers in different underlying anemias before and after deferasirox treatment
9. Prevalence and distribution of iron overload in patients with transfusion-dependent anemias differs across geographic regions: results from the CORDELIA study
10. Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia
11. Sustained improvements in myocardial T2* over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine
12. Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non-transfusion-dependent thalassaemia
13. Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients
14. Iron Overload and Hemolysis Modulate Monocytes and Inflammation in β-Thalassemia: 138
15. High index of suspicion for early diagnosis of alendronate-induced stage zero osteonecrosis of jaw in thalassaemia major
16. Approaching low liver iron burden in chelated patients with non-transfusion-dependent thalassemia: the safety profile of deferasirox
17. Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients
18. Prospective study of histomorphometry, biochemical bone markers and bone densitometric response to pamidronate in β-thalassaemia presenting with osteopenia-osteoporosis syndrome
19. Sudden exertional death in sickle cell trait
20. Response of iron overload to deferasirox in rare transfusion-dependent anaemias: equivalent effects on serum ferritin and labile plasma iron for haemolytic or production anaemias
21. Symptoms of depression and anxiety in patients with thalassemia: Prevalence and correlates in the thalassemia longitudinal cohort
22. Deferasirox—current knowledge and future challenges
23. Mechanisms for the shuttling of plasma non-transferrin-bound iron (NTBI) onto deferoxamine by deferiprone
24. Relation of myocardial T2* to right ventricular function in thalassaemia major
25. Efficacy and safety of deferasirox doses of >30 mg/kg per d in patients with transfusion-dependent anaemia and iron overload
26. Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions
27. Nature of non-transferrin-bound iron: studies on iron citrate complexes and thalassemic sera
28. Concepts and goals in the management of transfusional iron overload
29. Myocardial Tissue Characterization and the Role of Chronic Anemia in Sickle Cell Cardiomyopathy
30. Normalized Left Ventricular Volumes and Function in Thalassemia Major Patients With Normal Myocardial Iron
31. Left Ventricular Diastolic Function Compared with T2* Cardiovascular Magnetic Resonance for Early Detection of Myocardial Iron Overload in Thalassemia Major
32. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance
33. PRACTICAL MANAGEMENT OF IRON OVERLOAD: Review
34. A Risk-Benefit Assessment of Iron-Chelation Therapy
35. Leukocyte activity in the microcirculation of the leg in patients with chronic venous disease
36. The metabolites of nitric oxide in sickle-cell disease
37. ART. I. — Medical and Surgical Notes of Campaigns in the War with Mexico, during the years 1845, 1846, 1847, and 1848
38. Medical and Surgical Notes of Campaigns in the War with Mexico, during the years 1845, 1846, 1847, and 1848
39. ART. VI.—On the Climate and Salubrity of Fort Moultrie and Sullivanʼs Island, Charleston Harbour, S. C., with Incidental Remarks on the Yellow Fever of the City of Charleston
40. On the Climate and Salubrity of Fort Moultrie and Sullivanʼs Island, Charleston Harbour, S. C, with Incidental Remarks on the Yellow Fever of the City of Charleston
41. ART. IV.—Analysis of an “Official Report to the Surgeon-General, U. S. Army, on the use of large doses of Sulphate of Quinine in diseases of the South, with notices of the Climate and Diseases of Florida, &c. &c
42. VII.Medical and Surgical Notes of Campaigns in the War with Mexico, during the years 1845, 1846, 1847, and 1848
43. On the Climate and Salubrity of Fort Moultrie and Sullivanʼs Island, Charleston Harbour, S. C., with Incidental, Remarks on the. Yellow Fever of the City of Charleston
44. Art. V.—On the Climate and Salubrity of Fort Moultrie and Sullivanʼs Island, Charleston Harbour, S. C., with Incidental Remarks on the Yellow Fever of the City of Charleston.
45. Medical and Surgical Notes of Campaigns in the War with Mexico, during the years 1845, 1846, 1847, and 1848
46. ART. II–Medical and Surgical Notes of Campaigns in the War with Mexico, during the years 1845, 1846, 1847 and 1848
47. On the Climate and Salubrity of Port Moultrie and Sullicanʼs Leland, Charleston Harbour, S. C., with Incidental Remarks on the Fever of the City of Charleston
48. On the Climate and Salubrity of Fort Moultrie and Sullivanʼs Island, Charleston Harbour, S. C., with Incidental Remarks on the Yellow Fever of the City of Charleston
49. ART. VI.—On the Climate and Salubrity of Fort Moullrie and Sullivanʼs Island, Charleston Harbour, S. C., with Incidental Remarks on the Yellow Fever of the City of Charleston
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.